Status:
COMPLETED
Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
Lead Sponsor:
Alcon Research
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the efficacy of Olopatadine Nasal Spray with Azelastine Nasal Spray when treatments are utilized in conjunction with Fluticasone Nasal Spray for the treatment o...
Eligibility Criteria
Inclusion
- Able to provide consent/assent
- History of spring/summer allergic rhinitis
- Positive skin prick and/or intradermal test
- Absence of significant anatomic abnormalities, infection, bleeding, and mucosal ulcerations
- Non-pregnant (where applicable)
- Able to complete daily diary
Exclusion
- Smoker
- Concurrent disease such as rhinitis medicamentosa or large obstructive nasal polyps
- History of current chronic sinusitis
- Asthma
- Use of anti-allergy immunotherapy, corticosteroids, chronic use of long acting antihistamines
- History of severe, unstable, or uncontrolled cardiovascular, hepatic, renal and/or other diseases/illnesses
- History or evidence of nasolacrimal drainage system malfunction
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00845195
Start Date
March 1 2009
Last Update
April 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134